Indian Journal of Clinical Biochemistry

, Volume 26, Issue 2, pp 146–153

Quantitative Assessment of Expression of Lactate Dehydrogenase and its Isoforms 3 and 4 may Serve as Useful Indicators of Progression of Gallbladder Cancer: A Pilot Study

Authors

  • Tekcham Dinesh Singh
    • Centre for Genomics, Molecular and Human Genetics, School of Studies in ZoologyJiwaji University
  • Mustafa Ahmed Barbhuiya
    • Centre for Genomics, Molecular and Human Genetics, School of Studies in ZoologyJiwaji University
  • Sanjeev Gupta
    • Department of PathologyCancer Hospital and Research Institute (CHRI)
  • Braj Raj Shrivastav
    • Department of Surgery Cancer Hospital and Research Institute (CHRI)
    • Department of Surgery Gajra Raja Medical College (GRMC)
  • Viswajit Jalaj
    • Department of Surgery Cancer Hospital and Research Institute (CHRI)
  • Nidisha Agarwal
    • Department of Surgery Cancer Hospital and Research Institute (CHRI)
    • Centre for Genomics, Molecular and Human Genetics, School of Studies in ZoologyJiwaji University
Original Article

DOI: 10.1007/s12291-011-0117-3

Cite this article as:
Singh, T.D., Barbhuiya, M.A., Gupta, S. et al. Ind J Clin Biochem (2011) 26: 146. doi:10.1007/s12291-011-0117-3

Abstract

We have studied the expression of lactate dehydrogenase and its isoforms in gall bladder cancer, cholelithiasis and chronic cholecystitis. Quantitative and qualitative assays of lactate dehydrogenase and its various isoforms were carried out in the blood sera of patients and healthy controls along with parallel estimation of various liver function test enzymes. Statistical analysis was done using the software Graph Pad Prism. Significantly high expression of lactate dehydrogenase along with alkaline phosphatase and total bilirubin (P ≤ 0.05) was observed in all the three clinical conditions as compared to controls. LDH showed an increasing trend from stage I to stage IV of GBC indicating a significant positive association with the disease progression. The levels of LDH 3 and 4 isoforms appeared significantly more elevated in GBC than cholelithiasis or chronic cholecystitis. We suggest that a careful estimation of total LDH and its isoforms 3 and 4 alone or along with alkaline phosphatase and total bilirubin during different clinical stages, like chronic cholecystitis, cholelithiasis and GBC, may prove to be a potentially useful biomarker in the prognostic management of gall bladder diseases, specifically GBC.

Keywords

Gallbladder cancerLactate dehydrogenaseCholelithiasisChronic cholecystitis

Copyright information

© Association of Clinical Biochemists of India 2011